Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)

NCT02689362 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
146
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eurofarma Laboratorios S.A.